In contrast, serum CTRP9 levels were positively associated with BMI in morbidly obese subjects requiring bariatric surgery [17] and with obesity, insulin resistance, and arterial stiffness in subjects with type 2 diabetes (T2D) [18]. Here, C1QTNF9 is linked to obesity due to melanocortin 4 receptor deficiency.